Please login to the form below

Not currently logged in
Email:
Password:

Noven

This page shows the latest Noven news and features for those working in and with pharma, biotech and healthcare.

Hisamitsu's Noven unit signs Brisdelle deal with Shionogi

Hisamitsu's Noven unit signs Brisdelle deal with Shionogi

Will co-promote the menopausal hot flushes treatment. Noven is to co-promote its menopausal hot flushes treatment Brisdelle (paroxetine) with Shionogi. ... Noven, a US-based subsidiary of Hisamitsu Pharmaceutical, said the deal will help extend physician

Latest news

  • Pfizer enters ADHD market with Quillivant XR launch Pfizer enters ADHD market with Quillivant XR launch

    Shire's Daytrana (methylphenidate; now divested to Noven), Vyvanse (lisdexamfetamine) and Intuniv (guanfacine), as well as Johnson &Johnson's Concerta (methylphenidate).

  • News in brief, July 13, 2007

    Noven added that it expected the acquisition to provide an annual sales of over USD 500m beginning in 2012. ... Following closing, Phillip Satow, CEO and co-founder of JDS, may join Noven's board of directors.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    30. Immunocore/ Eli Lilly. Co-discovery /co-development, options (cost/profit share). ImmTAC (Immune mobilising mTCR Against Cancer) technology (discovery)    . 25+. Noven Therapeutics/ ANI Pharmaceuticals. Acquisition of NDA †. Lithobid

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics